GEORGE W. SMITH, M. D.; JOSEPH M. MILLER, M.D.
This content is PDF only. Please click on the PDF icon to access.
A review of the properties of stilbamidine (4:4′ stilbenedicarboxamidine) and observation of patients treated for various diseases with the drug revealed that its late chronic toxicity was confined to an unusual neuropathy. The progressive sensory changes of paresthesia, hypalgesia and anesthesia, usually confined to the face, were noted two to five months after a course of stilbamidine.1, 4, 5, 12, 13, 15, 16 Napier and Sen Gupta13 found a subjective disturbance of sensation over various distributions of the fifth cranial nerves. They suggested that the lesion was in the sensory nucleus of the trigeminal nerve in the pons. Collard and
SMITH GW, MILLER JM. THE RELIEF OF TIC DOULOUREUX WITH STILBAMIDINE1. Ann Intern Med. 1953;38:335–338. doi: 10.7326/0003-4819-38-2-335
Download citation file:
Published: Ann Intern Med. 1953;38(2):335-338.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use